Physician profile
Eric Bloom
NPI 1902874670
$621.53
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.67 · 2020: $42.14 · 2021: $24.11 · 2022: $135 · 2023: $186 · 2024: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurinia Pharma U.S., INC. | $179.72 | 2022-2023 | Lupkynis |
| Novartis Pharmaceuticals Corporation | $128.36 | 2024 | |
| Vifor Pharma, INC. | $81.70 | 2019-2022 | |
| Amgen INC. | $63.39 | 2019-2020 | |
| Fresenius USA Marketing, INC. | $56.17 | 2022-2023 | Velphoro |
| Astrazeneca Pharmaceuticals Lp | $36.41 | 2019-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $24.11 | 2021 | |
| Baxter Healthcare | $17.94 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $16.99 | 2024 | Jynarque |
| Akebia Therapeutics INC | $16.74 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Bloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.